ALT
Altimmune Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.
Market Cap: 28.8 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.altimmune.com
Shares Outstanding: 15.7 Million
Float: 10.6 Million
Dividend: 0.0 (0.0%)
Beta: 2.444308
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 646 Thousand
Ethical Flags
Longest drawdown: 693 trading days
From: 2017-01-10 To: 2019-10-18
Lowest Point:
Altimmune appoints Will Brown as CFO.
via: SeekingAlpha at 2019-06-12 07:15:24:000
Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...
Altimmune appoints Will Brown as CFO.
via: SeekingAlpha at 2019-06-12 07:15:24:000
Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-05-05 | 10.0 | 1.0 | 10.0 |